Free US stock valuation models and price target projections from professional analysts covering Wall Street expectations and analyst consensus. We help you understand fair value estimates and potential upside or downside scenarios for any stock you are considering. Our platform provides multiple valuation methods, comparable company analysis, and discounted cash flow models. Make smarter valuation decisions with our comprehensive tools and expert projections based on Wall Street research.
BeOne Medicines Ltd. American Depositary Shares (ONC) is trading at $295.27 as of May 1, 2026, posting a single-session gain of 1.54% amid muted overall market action for biopharmaceutical names. This analysis reviews recent market context for the ADS, key technical levels that have shaped recent price action, and potential near-term scenarios for traders and investors to monitor. No recent earnings data is available for ONC at this time, so price movement in recent weeks has been driven largely
What value at risk BeOne (ONC)? (Smart Money Flows) 2026-05-01 - Community Trade Ideas
ONC - Stock Analysis
3777 Comments
1005 Likes
1
Donitra
Influential Reader
2 hours ago
Anyone else trying to figure this out?
👍 29
Reply
2
Yasmina
Expert Member
5 hours ago
I read this and suddenly became quiet.
👍 243
Reply
3
Anahly
Engaged Reader
1 day ago
I hate realizing things after it’s too late.
👍 40
Reply
4
Leilaann
Active Reader
1 day ago
US stock return on invested capital analysis and economic value added calculations to identify truly exceptional businesses with durable competitive advantages. Our quality metrics help you find companies that generate superior returns on capital employed in their business operations. We provide ROIC analysis, economic value added calculations, and capital efficiency metrics for comprehensive quality assessment. Find quality businesses with our comprehensive quality analysis and return metrics for long-term investment success.
👍 193
Reply
5
Keshi
Consistent User
2 days ago
Too late… oh well.
👍 126
Reply
Disclaimer: Not investment advice. For informational purposes only. Past performance does not guarantee future results. Trading involves substantial risk of loss.